[HTML][HTML] Assessment of apolipoprotein (a) isoform size using phenotypic and genotypic methods
F Fogacci, V Di Micoli, A Avagimyan… - International Journal of …, 2023 - mdpi.com
Apolipoprotein (a)(apo (a)) is the protein component that defines lipoprotein (a)(Lp (a))
particles and is encoded by the LPA gene. The apo (a) is extremely heterogeneous in size …
particles and is encoded by the LPA gene. The apo (a) is extremely heterogeneous in size …
Lipoprotein (a): Cardiovascular risk and emerging therapies
M Fujino, SJ Nicholls - Expert Review of Cardiovascular Therapy, 2023 - Taylor & Francis
Introduction There is abundant evidence that elevated lipoprotein (a)[LP (a)] associates with
cardiovascular risk. Most lipid modifying therapies don't reduce Lp (a), but new technologies …
cardiovascular risk. Most lipid modifying therapies don't reduce Lp (a), but new technologies …
[HTML][HTML] The kringle IV type 2 domain variant 4925G> A causes the elusive association signal of the LPA pentanucleotide repeat
R Grüneis, H Weissensteiner, C Lamina… - Journal of Lipid …, 2022 - ASBMB
Abstract Lipoprotein (a)[Lp (a)] concentrations are regulated by the LPA gene mainly via the
large kringle IV-type 2 (KIV-2) copy number variation and multiple causal variants. Early …
large kringle IV-type 2 (KIV-2) copy number variation and multiple causal variants. Early …
The 10 essential questions regarding lipoprotein (a)
KM Kostner, GM Kostner - Current Opinion in Clinical Nutrition & …, 2024 - journals.lww.com
This review aims to answer important preclinical and clinical questions about the
metabolism and physiological role of Lp (a) and also outlines possible therapeutic …
metabolism and physiological role of Lp (a) and also outlines possible therapeutic …
Lipoprotein (a) Cut-Off in Chronic Kidney Disease Patients with a History of Cardiovascular Disease in Center Hospital University Souro SANOU, Burkina Faso
O Da, A Semde, A Kouraogo… - Advances in …, 2023 - science.sdpublishers.org
Patients living with chronic kidney disease (CKD) are at high risk of cardiovascular events.
Our aim in this study was to assess the cut-off value for lipoprotein (a)(Lp (a)) in CKD …
Our aim in this study was to assess the cut-off value for lipoprotein (a)(Lp (a)) in CKD …
CORRESPONDENCE: MNOS3 RS1799983 AND RS2070744 POLYMORPHISMS AND CHRONIC KIDNEY DISEASE AND CORONARY HEART DISEASE IN …
R Mungmunpuntipantip, V Wiwanitkit - Acta Endocrinologica …, 2022 - ncbi.nlm.nih.gov
Dear Editor, We would like to share ideas on the publication mNOS3 rs1799983 and
rs2070744 polymorphisms and their association with advanced chronic kidney disease and …
rs2070744 polymorphisms and their association with advanced chronic kidney disease and …